Back to HomeBeta

ICD-10 Coding for Uterine Leiomyosarcoma(C54.2, C55)

Complete ICD-10-CM coding and documentation guide for Uterine Leiomyosarcoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

uLMSMalignant Smooth Muscle Tumor of the Uterus

Related ICD-10 Code Ranges

Complete code families applicable to Uterine Leiomyosarcoma

C54-C55Primary Range

Malignant neoplasms of the uterus

This range includes codes for malignant neoplasms of the uterine corpus and unspecified parts of the uterus, relevant for coding uterine leiomyosarcoma.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C54.2Malignant neoplasm of myometriumUse when the tumor is confirmed to originate in the myometrium.
  • Histologic confirmation of smooth muscle origin
  • Presence of spindle cells with nuclear pleomorphism
  • Tumor cell necrosis
  • + 1 more
C55Malignant neoplasm of uterus, part unspecifiedUse when documentation does not specify the uterine subsite.
  • Used when the specific site of the uterine tumor is not documented.

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for uterine leiomyosarcoma

Essential facts and insights about Uterine Leiomyosarcoma

The ICD-10 code for uterine leiomyosarcoma is C54.2 when originating in the myometrium.

Primary ICD-10-CM Codes for uterine leiomyosarcoma

Malignant neoplasm of myometrium
Billable Code

Decision Criteria

clinical Criteria

  • Tumor confirmed in the myometrium with histological evidence.

Applicable To

  • Leiomyosarcoma of the myometrium

Excludes

  • Endometrial stromal sarcoma (C54.1)

Clinical Validation Requirements

  • Histologic confirmation of smooth muscle origin
  • Presence of spindle cells with nuclear pleomorphism
  • Tumor cell necrosis
  • Mitotic activity ≥10/10 HPF

Code-Specific Risks

  • Misclassification with C55 if the site is specified as myometrium.

Coding Notes

  • Ensure histological confirmation is documented to support the use of C54.2.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic radiation therapy

Z51.0
Use as primary when the encounter is for radiation therapy.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of endometrium

C54.1
Use C54.1 if the tumor originates from the endometrial tissue.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Uterine Leiomyosarcoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C54.2.

Impact

Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with coding specificity requirements., Financial: Potential for reduced reimbursement.

Mitigation Strategy

Ensure detailed site documentation in medical records., Educate providers on the importance of specifying tumor location.

Impact

Reimbursement: Incorrect coding may lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data for clinical and research purposes.

Mitigation Strategy

Use C54.2 when the tumor is confirmed in the myometrium.

Impact

High use of C55 without site specification can trigger audits.

Mitigation Strategy

Encourage detailed documentation of tumor site.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Uterine Leiomyosarcoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Uterine Leiomyosarcoma

Use these documentation templates to ensure complete and accurate documentation for Uterine Leiomyosarcoma. These templates include all required elements for proper coding and billing.

Pathology report for uterine leiomyosarcoma

Specialty: Pathology

Required Elements

  • Tumor size
  • Location
  • Histology
  • Mitotic count
  • Necrosis
  • Immunohistochemistry results

Example Documentation

Specimen: Uterus Tumor Size: 6 cm Location: Myometrium Histology: Spindle cells, severe atypia, 15 mitoses/10 HPF, geographic necrosis IHC: SMA+, desmin+, CD10-

Examples: Poor vs. Good Documentation

Poor Documentation Example
Uterine sarcoma identified.
Good Documentation Example
6 cm intramural uterine mass with irregular borders. Histology: Spindle cell proliferation, severe atypia, 15 mitoses/10 HPF, and geographic necrosis. Immunohistochemistry: SMA+, desmin+, CD10-
Explanation
The good example provides specific histological details and immunohistochemistry results necessary for accurate coding.

Need help with ICD-10 coding for Uterine Leiomyosarcoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more